TSC22 is thought to be a potent tumor suppressor in salivary cancer cells [8], [9] human gastric carcinoma cells [10], hepatic carcinoma [11], human astrocytic tumors [12], and large granular lymphocyte leukemia [13]. This evidence concerns the gene TSC22D1 and neoplasm.